Strategic Options Update: Buy this option up to $0.65
Today's Financial News - Posted March 10, 2009
Last week’s options pick is up 167%… with plenty of upside left. And TFN Strategic Trader’s Andre Snyder just issued a brand-new play…
by J. Christoph Amberger
Baltimore—TFN: This week looks like it’s custom-made for options traders! The markets are ready for a multi-day upward move… especially if the mark-to-market hearing goes well. And options prices have come down over the past two days as proven by the drop in the VIX.
To maximize gains on this volatile scenario, TFN Strategic Trader Andrew Snyder recommended one particular Call option today. There’s some risk in this play, with expiration in just under two weeks, but the potential is huge: “At their current price of $0.50, the breakeven on these options is $18. Shares of the stock are currently trading for $16.10, but traded above $18 as recently as last Thursday. With a little help from a market pop, this company should be above that level again before expiration.”
If you’ve followed Andy’s work over the years, you know that he likes to buy right alongside corporate insiders or major stakeholders. This is exactly what’s happening with this company. A major investment firm just bought over 4.3 million shares of the company at an average price of $19.23.
Andy writes: “Again, this is a risky play. But the reward far outweighs the downside!”
These options are still priced at $0.50, and Andy sees opportunity in buying up to $0.65. This is a straight-forward options play that anyone with Level 2 privileges can execute. If you feel ready to join our TFN Strategic Traders on this play , please follow this link…
By the way: TFN Strategic Trader Charter members are quickly realizing how smart a move they made. Through the power of leverage, we’re already seeing a powerful 167% surge on our Gene Switching option, with even more on the way. Investors who put just $1,000 into this simple strategy are already sitting on a position worth more than $2,167 since we first wrote about them in the TFNeNews last Wednesday. You may have missed out on some of the gains… but the remaining upside is HUGE! Don’t say we didn’t invite you!
Next Article: In-and-out strategies for alternative investment profits
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down